- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Complaint alleged Facebook/Twitter meeting adverts lacked sponsorship statements and reached the public. Panel initially found a Clause 22.4 breach for one Facebook…
Beacon was held responsible for a third-party agency’s promotional email about Episenta sent without proven prior consent. The Panel found the “opt-in”…
GSK ran RLS disease-awareness ads in GP journals pointing to a patient group website. The site later included content implying ropinirole was…
Roche/GSK challenged a competitor slide kit on Bonviva using FDA-review material. Panel found it disparaged Bonviva and misled readers by blurring FDA…
Guardian article alleged AstraZeneca promoted Crestor with entertainment and funded doctors to a Cannes bipolar meeting. Panel found the Cannes congress had…
PMCPA case AUTH/2188/12/08: complaint about conduct of a representative. The matter was ruled outwith the scope of the ABPI Code (2008). No…
Complaint about an “Andropause” website. PMCPA concluded the matter was outwith the scope of the ABPI Code; no breach was found. Undertaking…
AstraZeneca’s ‘Fixing Dad’ diabetes patient-engagement trailer sat within a promotional HCP medicines site and was used by field force. Panel ruled it…
PMCPA ruled Daiichi-Sankyo’s UK website “Products” page promoted POMs to the public by listing brand/generic names and indications plus condition/benefit statements, without…
PMCPA case AUTH/2904/11/16 (Director v Lundbeck) concerning clinical trial disclosure for Selincro. Outcome: No breach; matter was outwith the scope of the…
Janssen’s BSR “Pipelines in PsA” innovation theatre session was ruled not to be legitimate scientific exchange and to promote Tremfya for an…
PMCPA ruled ivironheart.co.uk was promotional for Vifor’s IV irons (Ferinject/Venofer). Missing prescribing info, AE reporting statement and certification; content misleading vs oral…
A Kisqali leaflet used at a breast cancer meeting was ruled misleading for not clearly limiting MONALEESA-7 survival data to the aromatase…
GSK’s asthma webinar registration page promoted Relvar but omitted prescribing info and PI location statement, and wasn’t reviewed under a prior undertaking—Clause…
Complaint alleged Nicorette journal ad used out-of-date prescribing information after SPC updates. Panel found SPC changes were minor and did not require…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.